George R Thompson
University of California, Davis
H-index: 59
North America-United States
Top articles of George R Thompson
Hypoxemic Respiratory Failure and Coccidioidomycosis-Associated Acute Respiratory Distress Syndrome
Open Forum Infectious Diseases
2024/2
Clinical testing guidance for histoplasmosis in patients with community-acquired pneumonia for primary and urgent care providers: Commentary on Enzyme Immunoassay Histoplasma …
Clinical Infectious Diseases
2024/1/3
Discovery and Repurposing of Pharmaceutical Agents as Antifungals: In vivo activity against Coccidioides
bioRxiv
2024
P30 Efficacy and safety of rezafungin in critically ill patients with candidaemia and/or IC: Outcomes of patients treated in the ICU from an integrated analysis of Phase 2 and …
JAC-Antimicrobial Resistance
2024/1
P29 Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and …
JAC-Antimicrobial Resistance
2024/1
George R Thompson
H-Index: 35
Matteo Bassetti
H-Index: 63
The dog as a sentinel and animal model for coccidioidomycosis
2024/1
George R Thompson
H-Index: 35
Comparison of coccidioidal complement fixation and quantitative immunodiffusion serology at a reference laboratory
Medical Mycology
2024/1
Utility of Microbial Cell Free DNA Next-Generation Sequencing for Diagnosis and Management of Infectious Diseases
Diagnostic Microbiology and Infectious Disease
2024/4/26
Infectious Diseases in a Changing Climate
JAMA
2024/4/16
George R Thompson
H-Index: 35
Novel Presentation of Coccidioidomycosis with Myriad Free-Floating Proteinaceous Spheres in the Pericardial Sac of a Southern Sea Otter (Enhydra lutris nereis)
The Journal of Wildlife Diseases
2024/1/1
Epidemiological, clinical, and genomic landscape of coccidioidomycosis in northeastern Brazil
Nature Communications
2024/4/12
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
2024/4/11
Epidemiological trends and clinical outcomes of cryptococcosis in a medically insured population in the United States: a claims-based analysis from 2017 to 2019
Therapeutic Advances in Infectious Disease
2024/4
403 Epithelial hypoxia maintains colonization resistance against Candida albicans
Journal of Clinical and Translational Science
2024/4
George R Thompson
H-Index: 35
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis
Antimicrobial Agents and Chemotherapy
2024/3/25
Invasive candidiasis
2018/5/11
Impact of climate change and natural disasters on fungal infections
2024/3/19
Jean-Pierre Gangneux
H-Index: 31
Matthias Egger
H-Index: 112
George R Thompson
H-Index: 35
Martin Hoenigl
H-Index: 37
The Burden of Invasive Fungal Disease Following CAR T-cell Therapy and Strategies for Prevention
2024/3/13
Reply to Williams et al
Clinical Infectious Diseases
2018/10/15
Glucocorticoids as a risk factor for infection and adverse outcomes in non‐HIV and non‐transplant patients with cryptococcal meningitis
Mycoses
2024/3
Co-Authors
